Application of tDCS Stimulation in Controlling Refractory Status Epilepticus
RecruitingNCT06344338Phase: NAStarted 2024-04-01
Summary
The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus
Eligibility
Sex
ALL
Min Age
14 Years
Max Age
80 Years
Locations
Xuanwu Hospital, Capital Medical UniversityBeijing, Beijing Municipality, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06344338